Brethine review

Brethine is a bronchodilator which is used in the treatment of symptoms associated with lung diseases such as asthma, emphysema, and bronchitis. Brethine has been proven effective at treating bronchospasms and the wheezing associated with bronchospasms.

Patients should always divulge their accurate medical history to the prescribing physician. Not all patients will be able to tolerate Brethine well and may require special monitoring or dosage adjustments, or may not be able to take Brethine at all. This depends entirely on the condition, its severity, and the patient’s overall degree of health. Patients with a medical history which includes diabetes, seizures, epilepsy, liver disease, kidney disease, hyperthyroidism, high blood pressure, or heart disease are likely to be adversely affected by Brethine.

Brethine was rated a category B pregnancy risk by the American Food and Drug Administration, which means that Brethine has not been proven to cause harm or birth defects in unborn babies but does pass through the mother’s breast milk and can affect a nursing infant. Patients who are pregnant or nursing should be advised of the risks and whether or not they outweigh the benefits prior to starting Brethine.

If the patient forgets to take a dose, the dose can be taken when it is remembered. However, taking doses too closely together or taking a double dose can lead to an overdose, thus the dose should be skipped if it is almost time for the next scheduled dose. Should that patient accidentally overdose on Brethine, emergency medical intervention should be sought. A patient who has overdosed may experience angina, tremors, weakness, seizures, nausea, vomiting, headache, chest pain, irregular heart rate, fluttering heart, and fainting.

Side effects are common when taking Brethine, although some side effects can be quite severe. Serious side effects require medical attention without delay. Serious side effects may include chest pain, irregular heart rate, and an allergic reaction. Serious allergic reactions often expose the patient to symptoms such as hives, difficulty breathing, and swelling of the lips, mouth, face, tongue, or throat.

More common and less serious side effects do not require medical treatment, although patients should report their side effects to the prescribing physician. Common side effects may include dry mouth, sweating, nausea, vomiting, diarrhea, insomnia, tremors, nervousness, headaches, lightheadedness, or dizziness.

There is a risk of drug interactions associated with Brethine. Brethine should not be dispensed without a thorough medical evaluation including a current medication list. Patients should never take additional medication, whether it is prescription or over the counter, herbal, or vitamins, without first inquiring with the prescribing physician. Medications that are known to have interactions with Brethine include additional oral or inhaled bronchodilator, tricyclic antidepressants, beta blockers, monoamine oxidase inhibitors, and products that contain caffeine such as decongestants, diet pills, and energy supplements.

Patients should be encouraged to avoid situations and environments that worsen or enhance their breathing condition. Patients who require an increase in their asthma medication should seek medical assistance, as this can be an indication of a pending serious asthma attack. Patients who have more difficulty breathing after starting Brethine should notify their physician immediately as this may indicate the medication is irritating the lungs rather than helping them.

Brethine has the following structural formula:

Chemical structure of brethine

• Molecular formula of brethine is C12H19NO3
• Chemical IUPAC Name is 5-(1-hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol
• Molecular weight is 225.284 g/mol
Brethine available : 2.5mg tablets

Generic name: Terbutaline

Brand name(s): Brethaire, Brican, Bricanyl, Bricar, Bricaril, Bricyn, Terbutalin, Terbutalina, Terbutalino, Terbutalinum

  Your Brethine review